NeuroMetrix to Exhibit at the 2012 Diabetic Foot Global Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Mar. 12, 2012--
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on
the diagnosis and treatment of neurological complications of diabetes
will be an exhibiting sponsor at the
Diabetic Foot Global Conference
(DFCon) from
March 15-17 in
Los Angeles.
“We are pleased to play a leading role at this conference and showcase
NC-stat® DPNCheck™, a diagnostic test that is useful in early
detection and monitoring of diabetic peripheral neuropathy (DPN),” said
Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer,
NeuroMetrix. “Medical professionals participating in the diabetes
workshop will receive valuable exposure to a fast , accurate, and
quantitative point-of-care approach to the early detection of DPN which
affects over 50% of people with diabetes and can lead to foot ulcers and
amputation. This is an opportunity to demonstrate our medical device
that aids in DPN diagnosis as well as to broaden company exposure in the
medical community.”
In addition to exhibiting at the conference, NeuroMetrix will have a
demonstration area during the hands-on workshop session at the
conference. The title of the workshop is “Dressings and Diagnostics” and
will feature a presentation titled “Quantitative Evaluation of Diabetic
Peripheral Neuropathy”. It will be held on Saturday, March 17.
The Diabetic Foot Global Conference is focused on amputation prevention,
diabetes management, and diabetic foot and diabetic wound care. It
includes scientific and clinical lectures and specialized workshops. It
is one of the premier annual conferences addressing the long-term
implications of diabetes including diabetic neuropathy. Attendees
include endocrinologists, podiatrists, primary care doctors and other
medical professionals specializing in diabetic care.
About NeuroMetrix
NeuroMetrix is a medical device company focused on the diagnosis and
treatment of the neurological complications of diabetes. The Company
currently markets products for the detection, diagnosis, and monitoring
of diabetic neuropathies such as diabetic peripheral neuropathy and
median neuropathy (carpal tunnel syndrome). For more information, please
visit http://www.neurometrix.com.
Source: NeuroMetrix
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
Chief
Financial Officer
neurometrix.ir@neurometrix.com
